Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Hematopoietic Stem Cell Transplantation in Sickle Cell Disease, Experience of a Brazilian Private Service

Hegta R. Figueiroa, Victor Gottardello Zecchin, Adriana Maria Paixao de Sousa da Silva, MArina Foltran Cela, Maria Lucia De Martino Lee, Fabricio Tera Romagnol, Fernanda Marinho Manga, Gabriela Camargo, Dimitra Oliveira Delijaicov, Leticia Santos Soares, Tomas Marzagão Barbuto, Ricardo Helman, Fabio R. Kerbauy, Phillip Scheinberg

Blood (2024) 144 (Supplement 1): 7322.

https://doi.org/10.1182/blood-2024-209967

Published: 2024

Journal Articles

Impact of the Availability of Novel Drugs on Overall Survival of Multiple Myeloma Patients: A Real-World Study

Leonardo Javier Arcuri, Cinthya Correa Silva, MD, Danielle Ovigli, Ricardo Helman, MD PhD, Mariana Kerbauy, Nelson Hamerschlak, MD PhD

Blood (2020) 136 (Supplement 1): 22–23.

https://doi.org/10.1182/blood-2020-142480

Published: 2020

Journal Articles

Combined Analysis of Whole Exome Sequencing Data in Philadelphia-Negative Myeloproliferative (Ph-negative MPNs) and Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPNs) Reveals Novel Recurrently Mutated Genes

Fabio P S Santos, MD, Raquel MA Paiva, PhD, Renato D Puga, MSc, Giulliana AR Goncalves, MSc, Tarcila Santos Datoguia, MD, Welbert Oliveira, PhD, Bianca Lisboa, PhD, Ricardo Helman, MD PhD, Guilherme Perini, Nelson Hamerschlak, MD PhD, Paulo Vidal Campregher, MDPhD

Blood (2017) 130 (Supplement 1): 4224.

https://doi.org/10.1182/blood.V130.Suppl_1.4224.4224

Published: 2017

Journal Articles

Analysis of Patterns of Co-Occurrence and Mutual Exclusivity of Gene Mutations in Philadelphia-Negative Myeloproliferative (Ph-negative MPNs) and Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPNs)

Fabio P S Santos, MD, Raquel MA Paiva, PhD, Renato D Puga, MSc, Giulliana AR Goncalves, MSc, Tarcila Santos Datoguia, MD, Welbert Oliveira, PhD, Bianca Lisboa, PhD, Ricardo Helman, MD PhD, Iracema Esteves, MD, Breno Gusmao, Nelson Hamerschlak, MD PhD, Paulo Vidal Campregher, MD PhD

Blood (2017) 130 (Supplement 1): 2934.

https://doi.org/10.1182/blood.V130.Suppl_1.2934.2934

Published: 2017

Journal Articles

Post-Transplant Lymphoproliferative Disorders in Transplant Recipients: 14-Yr Experience at the Hospital Israelita Albert Einstein - Brazil

Danielle Isadora Blumenschein, MD, Juliana Dall Agnol da Rocha, MD, Guilherme Fleury Perini, MD, Iracema Esteves, MD PhD, Alanna Marra P. S. Bezerra, MD, Denise da Cunha Pasqualin, MD, Andreza Alice Feitosa Ribeiro, MDPhD, Fabio Pires de Souza Santos, MD, Nelson Hamerschlak, MD PhD, Ricardo Helman, MDPhD

Blood (2016) 128 (22): 3047.

https://doi.org/10.1182/blood.V128.22.3047.3047

Published: 2016

Journal Articles

Whole Exome Sequencing of Philadelphia-Negative (Ph-negative) Myeloproliferative Neoplasms (MPNs) and Myelodysplastic/Myeloproliferative Disorders (MDS/MPD)

Fabio P S Santos, MD, Renato D Puga, MSc, Ricardo Helman, MD, Welbert Oliveira Pereira, PhD, Tarcila S Datoguia, MD, Bianca Lisboa, MSc, Mariana Miyagi, Evelyn HA da Mata, Rodrigo Santucci, MD, Guilherme F Perini, MD, Eizabeth Xisto Souto, MD, Carolina Kassab, MD, Leandro Padua, MD, Patricia W Bollman, MD, Rodolfo Soares, MD, Marcia Higashi, MD, Adriana Valente Fadel, MD, Juliane Musacchio, MD PhD, Ana Fernandes Schriefer, MD, Marco Aurelio Salvino, MD PhD, Danielle Leao Cordeiro De Farias, MD MSc, Leila Martins Perobelli, MD, Paulo A. A. Silveira, MD PhD, Nydia Bacal, MD, Joao Carlos Guerra, MD PhD, Alanna Mara P. S Bezerra, MD, Denise da Cunha Pasqualin, MD, Marinus M Lima, Erika MM Costa, MD, Vinicius R. P. Mattos, MD, Isabel C Bello, RN, Michelli Silva Diniz, RN, Sandra S Nakashima, RN, Elvira Velloso, MD PhD, Nelson Hamerschlak, MD PhD, Paulo Vidal Campregher, MD

Blood (2014) 124 (21): 4593.

https://doi.org/10.1182/blood.V124.21.4593.4593

Published: 2014

Journal Articles

The Presence of ASXL1 Mutations As Well As a Total Number of Myeloid Driver Mutations Higher Than Two Is Strongly Associated with the Diagnosis of Primary Myelofibrosis As Opposed to Essential Thrombocythemia

Paulo Vidal Campregher, MD, Ricardo Helman, MD, Welbert Oliveira Pereira, PhD, Renato D Puga, MSc, Bianca Lisboa, MSc, Evelyn Helena Ascendino, Mariana Miyagi, Sandra Nakashima Yoshida, Isabel C Bello, RN, Michelli Silva Diniz, RN, Guilherme Fleury Perini, MD, Tarcila S Datoguia, MD, Elvira Velloso, MD PhD, Joao Carlos Guerra, MD PhD, Paulo A. A. Silveira, MD PhD, Nydia Bacal, MD, Roberta Cardoso Petroni, Juliane Musacchio, MD PhD, Rodrigo Santucci, MD, Ana Fernandes Schriefer, MD, Marco A. Salvino, MD PhD, Rodolfo Soares, MD, Manuela Pinto Tibúrcio, Leila Martins Perobelli, MD, Eizabeth Xisto Souto, MD, Danielle Leao Cordeiro De Farias, MD MSc, Marcia Higashi, MD, Adriana Valente Fadel, MD, Carolina Kassab, MD, Leandro Padua, MD, Patricia W Bollman, MD, Denise da Cunha Pasqualin, MD, Alanna Mara P. S Bezerra, MD, Marinus de Moraes Lima, MD, Erika MM Costa, MD, Vinicius R. P. Mattos, MD, Fernando Ferreira Costa, MD PhD, Nelson Hamerschlak, MD PhD, Fabio Pires de Souza Santos, MD

Blood (2014) 124 (21): 4595.

https://doi.org/10.1182/blood.V124.21.4595.4595

Published: 2014

Journal Articles

Presence of JAK2V617F Mutation in Endothelial Cells from Budd-Chiari Syndrome Patients Is Not Correlated with Ph-Negative Myeloproliferative Neoplasm

Ricardo Helman, MD, Welbert Oliveira Pereira, PhD, Paulo Vidal Campregher, MD, Luciana Cavalheiro Marti, PhD, Nelson Hamerschlak, MD PhD, Isabel Bello, Sandra Saemi Nakashima, Carlos S Chiattone, MD PhD, Fabio P S Santos, MD

Blood (2014) 124 (21): 4998.

https://doi.org/10.1182/blood.V124.21.4998.4998

Published: 2014

Journal Articles

Genomic Profile of Patients with Triple Negative (JAK2, CALR and MPL) Essential Thrombocythemia and Primary Myelofibrosis

Paulo Vidal Campregher, MD, Ricardo Helman, MD, Welbert Oliveira Pereira, PhD, Renato D Puga, MSc, Bianca Garcia Lisboa, MSc, Evelyn Helena Ascendino, Mariana Miyagi, Sandra Nakashima Yoshida, Isabel Bello, Michelli Silva Diniz, RN, Guilherme Fleury Perini, MD, Elvira Velloso, MD PhD, Joao Carlos Guerra, MD PhD, Paulo A.A. Silveira, MDPhD, Nydia Bacal, MD, Roberta Cardoso Petroni, Juliane Musacchio, MD PhD, Rodrigo Santucci, MD, Ana Fernandes Schriefer, MD, Marco A. Salvino, MD PhD, Soares Almeida Rodolfo, MD, Manuela Pinto Tibúrcio, Leila Martins Perobelli, MD, Eizabeth Xisto Souto, MD, Danielle Leao Cordeiro De Farias, MD MSc, Marcia Higashi, MD, Adriana Valente Fadel, MD, Tarcila S Datoguia, MD, Carolina Kassab, MD, Leandro Padua, MD, Patricia W Bollman, MD, Fernando Ferreira Costa, MD PhD, Nelson Hamerschlak, MD PhD, Fabio Pires de Souza Santos, MD

Blood (2014) 124 (21): 4589.

https://doi.org/10.1182/blood.V124.21.4589.4589

Published: 2014

Journal Articles

The Clinical and Therapeutic Drug Monitoring of Oral and Intravenous Busulfan in Patients with Acute Leukemia That Underwent to Stem Cell Transplantation with a Test Dose of Busulfan

Iracema Esteves, PhD, Juliana F Fernandes, MD, Andreza Feitosa Ribeiro, MD PhD, Fabio P S Santos, MD, Ricardo Helman, MD, Claudio Castro Junior, MD, Vinicius R. P. Mattos, MD, Andrea Tiemi Kondo, MD, Adriana Seber, MD, Jose Salvador Rodrigues Oliveira, PhD, José Carlos Barros, MD PhD, Vergilio Antonio Renzi Colturato, MD, Nelson Hamerschlak, MD PhD, Fabio Rodrigues Kerbauy, PhD

Blood (2014) 124 (21): 5841.

https://doi.org/10.1182/blood.V124.21.5841.5841

Published: 2014

Journal Articles

High Incidence of Neurological Complications in Patients with Sickle Anemia Disease Undergoing Related Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation: Early Diagnosis and Treatment Can Chance the Prognosis

Ricardo Helman, Juliana Folloni Fernandes, PhD, Michelli Silva Diniz, RN, Fabio R. Kerbauy, MD PhD, Lucila Nassif Kerbauy, Eduardo Cerello Chapchap, Melina Brumatti, Nathalia da Silva Halley Neves, Alessandra Prandini Azambuja, Jose Mauro Kutner, MD PhD, Andreza Feitosa Ribeiro, MD PhD, Nelson Hamerschlak, MD PhD

Blood (2014) 124 (21): 5941.

https://doi.org/10.1182/blood.V124.21.5941.5941

Published: 2014

Journal Articles

Incidence and Impact of Activating Mutations of the RAS-RAF-MEK-ERK Pathway in Patients with Philadelphia-Negative (Ph-negative) Myeloproliferative Neoplasms (MPNs) and Myelodysplastic/Myeloproliferative Disorders–Unclassified (MDS/MPD-U)

Fabio PS Santos, MD, Bianca Lisboa, MSc, Tarcila S Datoguia, MD, Ricardo Helman, MD, Welbert Oliveira Pereira, PhD, Renato D Puga, MSc, Mariana Miyagi, Evelyn HA da Mata, Rodrigo Santucci, MD, Guilherme F Perini, MD, Eizabeth Xisto Souto, MD, Carolina Kassab, MD, Leandro Padua, MD, Patricia W Bollman, MD, Marcia Higashi, MD, Rodolfo Soares, MD, Adriana Valente Fadel, MD, Juliane Musacchio, MD PhD, Ana Fernandes Schriefer, MD, Marco Aurelio Salvino, MD PhD, Danielle Leao Cordeiro De Farias, MD MSc, Leila Martins Perobelli, MD, Erika MM Costa, MD, Marinus M Lima, Vinicius R. P. Mattos, MD, Paulo A. A. Silveira, MD PhD, Nydia Bacal, MD, Joao Carlos Guerra, MD PhD, Alanna Mara P. S Bezerra, MD, Denise da Cunha Pasqualin, MD, Isabel C Bello, RN, Michelli Silva Diniz, RN, Sandra S Nakashima, RN, Elvira Velloso, MD PhD, Nelson Hamerschlak, MD PhD, Paulo Vidal Campregher, MD

Blood (2014) 124 (21): 3172.

https://doi.org/10.1182/blood.V124.21.3172.3172

Published: 2014

Journal Articles

Weight Gain in the First 10 Days after Hematopoietic Stem Cell Transplantation (HSCT) Is a Risk Factor for Early Mortality

Blood (2014) 124 (21): 2471.

https://doi.org/10.1182/blood.V124.21.2471.2471

Published: 2014

Journal Articles

Haploidentical Hematopoietic Stem Cell Transplantation: A New Transplantation Modality Implemented In a Recent Accredited FACT Institution In Latin America

Blood (2013) 122 (21): 5596.

https://doi.org/10.1182/blood.V122.21.5596.5596

Published: 2013

Journal Articles

Activity Of a JAK1/JAK2 Inhibitor In a Patient With KIT-Mutated Systemic Mastocytosis (SM) Associated With Myelofibrosis

Fabio P S Santos, MD, Ricardo Helman, MD, Welbert O Pereira, PhD, Renato D Puga, MSc, Sandra S Nakashima, RN, Isabel C Bello, RN, Michelli S Diniz, RN, Nelson Hamerschlak, MD, PhD, Paulo Vidal Campregher, MD

Blood (2013) 122 (21): 5246.

https://doi.org/10.1182/blood.V122.21.5246.5246

Published: 2013

Journal Articles

Busulfan Targeted Dose In Hematopoietic Stem Cell Transplantation: The Impact In Toxicity, Sinusoidal Obstructive Syndrome and Survival

Blood (2013) 122 (21): 4584.

https://doi.org/10.1182/blood.V122.21.4584.4584

Published: 2013

Journal Articles

Role of Magnetic Ressonance Imaging – T2* in Hereditary Hemochromatosis.

Reijane Alves de Assis, MD, Fernando Uliana Kay, MD, Paulo Vidal Campregher, MD, Gilberto Szarf, MD, Fabiana Mendes Conti, MD, Michelli da Silva Diniz, Roberta Sitnik, PhD, Morgani Rodrigues, MD, Ricardo Helman, MD, Marcelo Funari, MD, Nelson Hamerschlak, MD, PhD

Blood (2012) 120 (21): 2096.

https://doi.org/10.1182/blood.V120.21.2096.2096

Published: 2012

Journal Articles

Magnetic Resonance Imaging (MRI) Detection of Iron Overload In Patients with Myelodysplastic Syndrome (MDS),

Fabio P S Santos, MD, Claudia Bley, MD, Ricardo Helman, MD, Guilherme Fleury Perini, MD, Leandro de Padua Silva, MD, Isabel Bello, Carolina Kassab, MD, Breno Pannia Esposito, PhD, Murilo Sergio S. Ribeiro, MD, Cesar Higa Nomura, MD, Fernando Uliana Kay, MD, Ronaldo Hueb Baroni, MD, Elvira RP Velloso, MD, PhD, Nelson Hamerschlak, MD

Blood (2011) 118 (21): 3827.

https://doi.org/10.1182/blood.V118.21.3827.3827

Published: 2011

Journal Articles

Potential Benefits of Extended Genotype Matching to Chronically Transfused Patients with Sickle Cell Disease

Ricardo Helman, MD, Rodolfo Cancado, MD, PhD, Mariza A Mota, MD, Marcia R Dezan, Jose Mauro Kutner, MD, PhD, Carlos S Chiattone, MD, PhD, Lilian Castilho, PhD

Blood (2011) 118 (21): 2144.

https://doi.org/10.1182/blood.V118.21.2144.2144

Published: 2011

Journal Articles

Risk Factors and Mortality Associated with CMV Reactivation Post Autologous Stem Cell Transplantation.

Claudia Bley, MD, Fabio PS Santos, MD, Guilherme Fleury Perini, MD, Ricardo Helman, Andreza Alice Feitosa Ribeiro, MD, PhD, Jose Mauro Kutner, MD, PhD, Jairo Sobrinho, Angela Tavares, Jacyr Pasternak, Fabio R. Kerbauy, MD, Nelson Hamerschlak

Blood (2010) 116 (21): 4531.

https://doi.org/10.1182/blood.V116.21.4531.4531

Published: 2010

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Hematopoietic Stem Cell Transplantation in Sickle Cell Disease, Experience of a Brazilian Private Service

Impact of the Availability of Novel Drugs on Overall Survival of Multiple Myeloma Patients: A Real-World Study

Combined Analysis of Whole Exome Sequencing Data in Philadelphia-Negative Myeloproliferative (Ph-negative MPNs) and Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPNs) Reveals Novel Recurrently Mutated Genes

Analysis of Patterns of Co-Occurrence and Mutual Exclusivity of Gene Mutations in Philadelphia-Negative Myeloproliferative (Ph-negative MPNs) and Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPNs)

Post-Transplant Lymphoproliferative Disorders in Transplant Recipients: 14-Yr Experience at the Hospital Israelita Albert Einstein - Brazil

Whole Exome Sequencing of Philadelphia-Negative (Ph-negative) Myeloproliferative Neoplasms (MPNs) and Myelodysplastic/Myeloproliferative Disorders (MDS/MPD)

The Presence of ASXL1 Mutations As Well As a Total Number of Myeloid Driver Mutations Higher Than Two Is Strongly Associated with the Diagnosis of Primary Myelofibrosis As Opposed to Essential Thrombocythemia

Presence of JAK2V617F Mutation in Endothelial Cells from Budd-Chiari Syndrome Patients Is Not Correlated with Ph-Negative Myeloproliferative Neoplasm

Genomic Profile of Patients with Triple Negative (JAK2, CALR and MPL) Essential Thrombocythemia and Primary Myelofibrosis

The Clinical and Therapeutic Drug Monitoring of Oral and Intravenous Busulfan in Patients with Acute Leukemia That Underwent to Stem Cell Transplantation with a Test Dose of Busulfan

High Incidence of Neurological Complications in Patients with Sickle Anemia Disease Undergoing Related Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation: Early Diagnosis and Treatment Can Chance the Prognosis

Incidence and Impact of Activating Mutations of the RAS-RAF-MEK-ERK Pathway in Patients with Philadelphia-Negative (Ph-negative) Myeloproliferative Neoplasms (MPNs) and Myelodysplastic/Myeloproliferative Disorders–Unclassified (MDS/MPD-U)

Weight Gain in the First 10 Days after Hematopoietic Stem Cell Transplantation (HSCT) Is a Risk Factor for Early Mortality

Haploidentical Hematopoietic Stem Cell Transplantation: A New Transplantation Modality Implemented In a Recent Accredited FACT Institution In Latin America

Activity Of a JAK1/JAK2 Inhibitor In a Patient With KIT-Mutated Systemic Mastocytosis (SM) Associated With Myelofibrosis

Busulfan Targeted Dose In Hematopoietic Stem Cell Transplantation: The Impact In Toxicity, Sinusoidal Obstructive Syndrome and Survival

Role of Magnetic Ressonance Imaging – T2* in Hereditary Hemochromatosis.

Magnetic Resonance Imaging (MRI) Detection of Iron Overload In Patients with Myelodysplastic Syndrome (MDS),

Potential Benefits of Extended Genotype Matching to Chronically Transfused Patients with Sickle Cell Disease

Risk Factors and Mortality Associated with CMV Reactivation Post Autologous Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only